eGnome developed a program to identify probiotic strains through advanced genomic analysis, in collaboration with the Ministry of Food and Drug Safety. This initiative aims to enhance the safety and efficacy of probiotic products by providing precise genomic information. The program's success highlights eGnome's capability in leveraging genomic technologies to improve public health and nutritional products. The research has garnered attention from various media outlets, showcasing its impact on the probiotic industry.